Abstract
Silencing of tumor suppressor and tumor‐related genes by hyper‐methylation at promoter CpG islands is frequently found in human tumors, including gastric cancer. Promoter methylation is not restricted to cancer cells, and is also present in non‐neoplastic cells as an age‐related tissue‐specific phenomenon. To clarify the physiological consequence of DAP‐kinase and RUNX3 age‐related methylation in gastric epithelia, we investigated the promoter methylation status of these genes in both neoplastic and non‐neoplastic gastric epithelia obtained at autopsy and surgery, as well as in 10 gastric cancer cell lines. Methylation of DAP‐kinase and RUNX3 was detected in 10% (1/10) and 70% (7/10) of the cell lines, respectively, and was almost concordant with their expression status. Among autopsy samples, methylation of these genes was not seen in non‐neoplastic gastric epithelia from persons who were aged 22 years and below (0%; 0/4). DAP‐kinase was methylated in 87% (13/15) of non‐neoplastic gastric epithelia of persons who were aged 45 years or older, while RUNX3 methylation in non‐neoplastic gastric epithelia was restricted to individuals who were aged 77 years or older. Among samples obtained from patients with stomach cancer, methylation was observed in both the neoplastic and the corresponding non‐neoplastic gastric epithelia; 43% (40/93) and 73% (68/93) for DAP‐kinase, and 45% (42/93) and 8% (7/93) for RUNX3, respectively. Frequencies of DAP‐kinase and RUNX3 methylation differed significantly in non‐neoplastic gastric epithelia (P<0.01), although those in gastric cancers were almost the same. RUNX3 methylation is mostly cancer‐specific, except for very old individuals, and therefore may be a possible molecular diagnostic marker and malignancy predictor. (Cancer Sci 2003; 94: 360–364)
References
- 1. Kass SU, Pruss D, Wolffe AP. How does DNA methylation repress transcription? Trends Genet 1997; 13: 444–9. [DOI] [PubMed] [Google Scholar]
- 2. Razin A, Cedar H. DNA methylation and gene expression. Microbiol Rev 1991; 55: 451–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 2: 163–7. [DOI] [PubMed] [Google Scholar]
- 4. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225–9. [PubMed] [Google Scholar]
- 5. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999; 83: 309–13. [DOI] [PubMed] [Google Scholar]
- 6. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ. E‐Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000; 92: 569–73. [DOI] [PubMed] [Google Scholar]
- 7. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou T, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999; 59: 1090–5. [PubMed] [Google Scholar]
- 8. Schneider BG, Gulley ML, Eagan P, Bravo JC, Mera R, Geradts J. Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein‐Barr virus and anatomic location in the body of the stomach. Hum. Pathol 2000; 31: 45–50. [DOI] [PubMed] [Google Scholar]
- 9. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536–40. [DOI] [PubMed] [Google Scholar]
- 10. Issa JP, Vertino PM, Boehm CD, Newsham IF, Baylin SB. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA 1996; 93: 11757–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998; 58: 5489–94. [PubMed] [Google Scholar]
- 12. Issa JP. CpG‐island methylation in aging and cancer. Curr Top Microbiol lmmunol 2000; 249: 101–18. [DOI] [PubMed] [Google Scholar]
- 13. Endoh Y, Tamura G, Ajioka Y, Watanabe H, Motoyama T. Frequent hypermethylation of the hMLH1 gene promoter in differentiated‐type tumors of the stomach with the gastric foveolar phenotype. Am J Pathol 2000; 157: 717–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T. Promoter methylation status of E‐cadherin, hMLH1 and p16 genes in non‐neoplastic gastric epithelia. Am. J Pathol 2002; 161: 399–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Cohen O, Kimichi A. DAP‐kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Diff 2001; 8: 6–15. [DOI] [PubMed] [Google Scholar]
- 16. Kissil JL, Feinstein E, Cohen O, Jones PA, Tsai YC, Knowles MA, Eydmann ME, Kimichi A. DAP‐kinase loss of expression in various carcinoma and B‐cell lymphoma cell line: possible implications for role as tumor suppressor gene. Oncogene 1997; 15: 403–7. [DOI] [PubMed] [Google Scholar]
- 17. Tang X, Khuri R, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L. Hypermethylation of the Death‐Associated Protein (DAP) kinase promoter and aggressiveness in stage I non‐small cell lung cancer. J Natl Cancer Inst 2000; 18: 1511–6. [DOI] [PubMed] [Google Scholar]
- 18. Cohen MM Jr. RUNX genes, neoplasia, and cleidocranial dysplasia. Am J Med Genet 2001; 104: 185–8. [PubMed] [Google Scholar]
- 19. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113–24. [DOI] [PubMed] [Google Scholar]
- 20. Toyota M, Ahuja N, Ohe‐Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe‐Toyota M, Imai K, Baylin SB, Issa JP. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999; 59: 5438–42. [PubMed] [Google Scholar]
- 22. Nakagawa H, Nuovo GJ, Zervos EE, Martin EW Jr, Salovaara R, Aaltonen LA, de la Chapelle A. Age‐related hypermethylation of the 5′ region of MLHI in normal colonic mucosa is associated with microsatellite‐unstable colorectal cancer development. Cancer Res 2001; 61: 6991–5. [PubMed] [Google Scholar]
- 23. Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y, Suzuki H, Yawata A, Kusano M, Fujita M, Hosokawa M, Yanagihara K, Tokino T, Imai K. DNA methylation and histone deacetylation associated with silencing DAP‐kinase gene expression in colorectal and gastric cancers. Br J Cancer 2002; 86: 1817–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847–51. [PubMed] [Google Scholar]
- 25. Honda T, Tamura G, Waki T, Jin Z, Sato K, Motoyama T, Kimura W, Kawata S, Nishizuka S, Murakami Y. Hypermethylation of TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res 2002; 93: 857–60. [DOI] [PMC free article] [PubMed] [Google Scholar]